17:04 XFML Xinhua Finance raises guidance above consensus (8.54 +1.1 
XFML raises Q3 adjusted net income per ADS guidance to $0.20-0.21 vs $0.12 Reuters consensus; revs $38-40 mln vs $36.65 mln Reuters consensus. Co cites stronger than expected growth in its business as well as contribution from acquisitions.
17:03 FNM Fannie Mae announces plans to file its first, second and third quarter reports on Nov 9 with the SEC
…
17:03 DECC D & E Communications reports in-line (14.34 -0331)
Reports Q3 (Sept) earnings of $0.18 per share, excluding items, in-line with the Reuters dual-analyst est of $0.18; revenues fell 5.9% year/year to $38.2 mln vs the $38.6 mln Reuters dual-analyst est.
17:02 RIMM Research In Motion Announces Court Approval of Definitive Settlement to End Shareholder Litigation
…
17:01 XFML sees Q3 ADS above consensus
16:59 BKMU Bank Mutual announces that it has approved a 3 mln share repurchase authorization (10.27 -0.14)
16:59 XOM Exxon Mobil: Releases new outlook for energy, annual energy demand growth to increase 1.3%/yr from ‘05-’30
…
16:58 SYKE Sykes Enterprises reports Q3 (Sep) results, revs in-line; guides Q4 EPS in-line, revs above consensus (16.79 -0.43)
Reports Q3 (Sep) earnings of $0.30 per share, includes gain, may not be comparable to the Reuters Estimates consensus of $0.19; revenues rose 18.0% year/year to $176.1 mln vs the $175 mln consensus. Co issues in-line EPS guidance for Q4, sees EPS of $0.24-0.26 vs. $0.26 consensus; sees Q4 revs of $187-192 mln vs. $180.72 mln consensus.
16:57 VIV Vivo Participacoes swings to profit in Q3 - Reuters (5.60 -0.0
Reuters reports the co posted a net profit of 4.4 mln reais ($2.51 mln) for Q3 compared with a loss of 196.9 mln reais in the year-earlier period. Vivo, a joint venture owned by Portugal Telecom and Spain’s Telefonica (TEF), had reported a loss of 112.8 mln reais in the Q2. Earnings before interest, taxes, depreciation and amortization, rose to 833.3 mln reais in the third quarter from 715.6 mln reais in the same period a year earlier.
16:56 SYKE sees Q4 $0.24-0.26 vs $0.26 Reuters consensus; sees revs $187-192 mln vs $180.72 mln Reuters consensus
16:56 SYKE prelim $0.30 includes gain, may not be comparable to $0.19 Reuters consensus; revs $176.1 mln vs $174.96 mln Reuters consensus
16:55 BXG Bluegreen reports Q3 (7.37 +0.14)
Reports Q3 (Sept) earnings of $0.45 per share, includes items, may not be comparable to than the Reuters Estimates consensus of $0.33; revenues rose 4.8% year/year to $180.9 mln vs the $231.2 mln consensus.
16:54 SGP Schering-Plough announces that Addition of Integrilin to Bivalirudin plus standard of care, inhibits platelet aggregation in patients undergoing elective coronary stenting (29.46 -0.50)
Schering-Plough (SGP) and The Sinai Center for Thrombosis Research at Sinai Hospital of Baltimore announce results of the recently completed CLEAR Platelets 2 study, showing that Integrilin, a potent glycoprotein IIb- IIIa inhibitor, significantly inhibited platelet aggregation when added to bivalirudin, compared to bivalirudin alone, in patients undergoing elective coronary stenting. CLEAR Platelets 2 demonstrated that when added to bivalirudin, Integrilin significantly decreased platelet aggregation in response to multiple stimuli, thereby producing increased platelet inhibition. Results were statistically significant for all measurements of platelet aggregation induced by multiple agonists.
16:52 RSG Republic Services beats by $0.02; reaffirms Fy07 EPS guidance, above consensus (33.80 -0.04)
Reports Q3 (Sept) earnings of $0.46 per share, excluding charges, $0.02 better than the Reuters Estimates consensus of $0.44; revenues rose 2.4% year/year to $806.2 mln vs the $820 mln consensus. Co reaffirms FY07 EPS of $1.65-1.66, excl $0.18 charge, vs $1.64 Reuters consensus.
16:51 BKR Michael Baker beats by $0.22; misses on revs (50.14 +0.24)
Reports Q3 (Sep) earnings of $0.72 per share, $0.22 better than the Reuters Estimates consensus of $0.50; revenues rose 7 year/year to $182.20 mln vs the $190.62 consensus. “…We expect our primary markets to remain strong, and to show continued improvement in our financial results for the remainder of this year and into 2008.” He added that the Board of Directors continues to pursue the sale of the Energy segment with the assistance of its financial adviser and discussions with several potential buyers were in process at Sep 30, 2007.
16:49 FDO Family Dollar announces authorization to purchase $150 mln of common stock (22.91 -0.70)
16:49 VR Validus Holdings beats by $0.56 (25.25 -0.59)
Reports Q3 (Sept) earnings of $1.78 per share, $0.56 better than the Reuters Estimates consensus of $1.22; revenues rose 206% year/year to $237.4 mln vs the $216.3 mln consensus.
16:47 BKR prelim $0.72 vs $0.50 Reuters consensus; revs $182.2 mln vs $190.62 mln Reuters consensus
16:44 OUTD Outdoor Channel to restate 2007 first, second quarters (8.26 -0.41)
Co announces that in connection with a review of its financial statements with its independent registered public accounting co, the co determined that a correction is needed in the amortization period for the recognition of non-cash, share-based compensation costs previously expensed in the first two quarters of 2007 relating to performance units granted in the Q4 of 2006. Accordingly, the co will restate its consolidated financial statements included in its quarterly report on Form 10-Q for the first and second quarters ended March 31, 2007 and June 30, 2007. While the adjustments will materially impact the co’s financial statements for the first and second quarters of 2007, the overall compensation expense related to these performance units is expected to remain at $6.6 mln for the full year ending December 31, 2007. The compensation expense related to performance units will be adjusted from $1,653,000 quarterly to $2,995,000 in the first quarter and to $2,002,000 in the second quarter of 2007.
16:42 UA Under Armour reports form 4 filing for Chairman and CEO; sales for asset diversification, tax and estate planning and charitable giving purposes (51.37 -4.70)
Co announced that Kevin Plank, Chairman and CEO, filed a Form 4 with the SEC to report the sale of stock. On November 1, 2007, Mr. Plank and his family foundation and trusts, sold pursuant to Rule 144, 1.5 mln shares of Under Armour stock, consisting of 750K shares of Class A Common Stock and 750K shares of Class B Common Stock. The sales were done for asset diversification, tax and estate planning and charitable giving purposes.
16:41 AUDC Audiocodes beats by $0.01, reports revs in-line (6.49 +0.40)
Reports Q3 (Sep) earnings of $0.06 per share, excluding non-recurring items, $0.01 better than the Reuters Estimates consensus of $0.05; revenues rose 0.7% year/year to $40.4 mln vs the $40 mln consensus.
16:41 CCRT CompuCredit Earnings Color (16.36 -0.97) -Update-
Reuters Estimates is telling us that, adjusted for securitisation and provision to charge, an actual of $0.95 per share is comparable to Reuters estimates of $1.30. See earlier comment at 16:19.
16:41 AUDC prelim $0.06, ex items vs $0.05 Reuters consensus; revs $40.4 mln vs $40.02 mln Reuters consensus
16:40 CRL Charles River reports Q3 (Sep) results, beats on revs; guides FY07 EPS above consensus, revs above consensus (57.12 -0.37)
Reports Q3 (Sep) earnings of $0.69 per share, excludes option expense, may not be comparable to the Reuters Estimates consensus of $0.62; revenues rose 18.6% year/year to $314 mln vs the $307.3 mln consensus. Co raises EPS guidance for FY07, sees EPS of $2.56-2.59 vs. $2.52 consensus, up from $2.47-2.53; raises FY07 revs of $1.21-1.23 bln vs. $1.2 bln consensus, up from $1.19-1.21 bln.
16:39 ASCA Ameristar Casinos reports EPS in-line, beats on revs; guides Q4 EPS in-line (30.51 -1.44)
Reports Q3 (Sep) earnings of $0.34 per share, in-line with the Reuters Estimates consensus of $0.34; revenues rose 4.7% year/year to $265.4 mln vs the $260.7 mln consensus. Co issues in-line guidance for Q4, sees EPS of 0.22-0.26 vs. $0.26 consensus. Co comments that, “…year-to-date results for Resorts East Chicago are significantly less than originally anticipated. We now expect proforma EBITDA for the full year 2007 to be $54 mln to $55 mln, adjusted to exclude the impact of integration expenses and the increase in property taxes…”
16:38 CRK Comstock beats by $0.10, beats on revs (34.47 -0.90)
Reports Q3 (Sep) earnings of $0.37 per share, $0.10 better than the Reuters Estimates consensus of $0.27; revenues rose 32.1% year/year to $171.1 mln vs the $158.4 mln consensus.
16:38 BZH Beazer Homes announces the suspension of quarterly dividend; sees Q4 non-cash pre-tax charges of approximately $230 mln (9.52 -0.12)
Co provided certain unaudited and preliminary fourth quarter financial and operating data and also announced further steps to reduce costs and improve operating efficiencies in response to continued deterioration in the housing market. The co currently expects results for the fourth quarter of fiscal 2007 to include non-cash pre-tax charges to abandon land option contracts, to recognize inventory impairments and to record impairments and land option abandonments in joint ventures of approximately $230 mln. In addition, the co is currently in the process of evaluating the recoverability of its goodwill, which may result in impairment charges. “We maintain the view that the long term fundamentals for housing remain compelling and that our strategic initiatives to differentiate Beazer Homes in the eyes of the consumer and to allocate capital and resources in order to enhance long term shareholder value will position us well for the future. At the same time, we must continue to adapt to the realities of the current market by remaining disciplined in our operating approach and continuing to focus on initiatives aimed at responding to what we believe will continue to be a challenging environment in the near term. These initiatives include reductions in direct costs, overhead expenses and land spending, and an intense focus on sales and marketing efforts to reduce unsold home inventories, all with the aim of generating cash.” The co also announced today that its Board of Directors voted to suspend the co’s quarterly dividend of $0.10 per share. The Board concluded that this action, which will allow the co to conserve approximately $16 mln of cash on an annual basis, is prudent in light of the continued deterioration in the housing market.
16:37 HLEX HealthExtras misses by $0.02, misses on revs; guides FY08 EPS below consensus, revs above consensus (27.80 -0.73)
Reports Q3 (Sep) earnings of $0.23 per share, $0.02 worse than the Reuters Estimates consensus of $0.25; revenues rose 37.3% year/year to $498.4 mln vs the $506.8 mln consensus. Co issues FY08 guidance, sees EPS of $1.17-1.25 vs. $1.28 consensus; sees FY08 revs in excess of $2.50 bln vs. $2.37 bln consensus.
16:36 JRVR James River Group reports Q3 EPS of $0.67 vs $0.64 Reuters consensus; revs increased 19.6% from a year ago to $74.94 mln vs $64.39 mln Reuters consensus (34.24 +0.09)
16:36 WRNC Warnaco Group beats by $0.18, beats on revs; guides FY07 EPS in-line (37.38 -0.96)
Reports Q3 (Sep) earnings of $0.67 per share, excluding non-recurring items, $0.18 better than the Reuters Estimates consensus of $0.49; revenues rose 13.1% year/year to $474.8 mln vs the $464.3 mln consensus. Co issues in-line guidance for FY07, sees EPS of $2.10-2.18, excluding non-recurring items, vs. $2.11 consensus.
16:36 BLT Blount Intl announces sale of Forestry Division to Caterpillar (11.47 -0.51)
The co announces and simultaneously closed the sale of its Forestry Division to Caterpillar Forest Products, a wholly owned subsidiary of Caterpillar (CAT). Blount received consideration of $77.3 mln for the sale. Proceeds received upon completion of the transaction are subject to certain post-closing adjustments and will be utilized to reduce debt and pay applicable taxes and transaction fees. The co will recognize a gain on the sale from this transaction in the 4Q of this year. It is estimated that the gain on sale will be between $10 mln and $12 mln ($0.21 and $0.25 per diluted share). Net cash proceeds after payment of taxes and fees are estimated to be between $46 mln and $48 mln in the fourth quarter.
16:34 HLEX sees FY08 $1.17-1.25 vs $1.28 Reuters consensus; sees revs exceeding $2.5 bln vs $2.37 bln Reuters consensus
16:34 CRL raises FY07 revs guidance; sees growth of 14-16%, which equates to ~$1.21-1.23 bln vs $1.20 bln Reuters consensus
16:34 WRNC sees FY07 $2.10-2.18 vs $2.11 Reuters consensus
16:34 MRK Merck: Investigational extended-release Niacin/Laropiprant coadministered with Simvastatin had significant additive effects on LDL-C, HDL-C and triglycerides in phase III study (55.93 -0.11)
Extended-release niacin/laropiprant coadministered with simvastatin had significant additive effects on reducing LDL-cholesterol, increasing HDL-cholesterol and reducing triglyceride levels in a Phase III study with patients with primary hypercholesterolemia or mixed dyslipidemia.
16:33 WRNC prelim $0.67 vs $0.49 Reuters consensus; revs $474.8 mln vs $464.25 mln Reuters consensus
16:33 HLEX prelim $0.23 vs $0.25 Reuters consensus; revs $498.4 mln vs $506.78 mln Reuters consensus, $494.64 mln First Call
16:33 LOCM Local.com misses by $0.04, reports revs in-line; guides Q4 EPS and revs below consensus (5.08 -0.06)
Reports Q3 (Sep) loss of $0.71 per share, $0.04 worse than the Reuters Estimates consensus of ($0.67); revenues rose 38.2% year/year to $5.6 mln vs the $5.7 mln consensus. Co issues GAAP downside guidance for Q4, sees EPS of ($0.17)-($0.18), vs ($0.14) consensus; sees Q4 revs of $5.7-5.9 vs. $6.29 mln consensus.
16:33 CRL sees FY07 $2.56-2.59, excl option expense, may not be comparable to $2.52 Reuters consensus; sees revs growth of 14-16%
16:32 CORE Core-Mark announces letter of intent with MAPCO Express (33.99 -0.65)
16:31 EXEL Exelixis reports Q3 (Sep) results, misses on revs; guides FY07 revs below consensus (10.23 )
Reports Q3 (Sep) loss of $0.14 per share, may not be comparable to the Reuters Estimates consensus of ($0.20); revenues rose 13.8% year/year to $26.8 mln vs the $35.7 mln consensus. Co issues downside guidance for FY07, sees FY07 revs of $110-120 mln vs. $130.88 mln consensus.
16:31 LOCM sees Q4 GAAP ($0.17)-($0.1 vs ($0.14) Reuters consensus; sees revs $5.7-5.9 mln vs $6.29 mln Reuters consensus
16:31 THC Tenet Healthcare, SEIU Reach labor agreements (3.23 +0.03)
Co announces it has reached agreements with the SEIU on terms for separate multi-year contracts in California, Florida and with the national organization. The California wage agreement covers 5,700 SEIU-affiliated employees at 14 hospitals in California and expires on March 31, 2011. The Florida wage agreements cover 2,300 SEIU-affiliated employees at three hospitals in Florida that expire on different dates in 2010. The agreement with the national organization also provides a structured process that would permit Tenet nurses and other employees at 10 hospitals to decide whether or not to join a union. That agreement continues through Dec. 31, 2011.
16:30 CRL prelim $0.69 vs $0.62 Reuters consensus; revs $314 mln vs $307.26 mln Reuters consensus, $298.84 mln First Call
16:30 FSLR First Solar announces additional four production lines to support new long term module supply agreements totalling 557MW (148.10 +1.54) -Update-
The co announces that it has entered into new long term module supply agreements with a subsidiary of international investment and funds and asset manager Babcock & Brown, and Ecostream Switzerland GmbH, a subsidiary of Econcern BV, which focuses on developing solutions for sustainable energy supply. The new agreements expand contracted module volume by a total of 557MW, allowing for additional sales of approximately $1 bln at an assumed exchange rate of $1.30/E1.00 over the period of 2008 to 2012. The agreements are structured on terms similar to First Solar’s existing long term supply agreements.
16:30 UDR United Dominion reports FFOs in-line, revs in-line; guides Q4 FFOs in-line (21.59 -0.49)
Reports Q3 (Sep) funds from operations of $0.47 per share, in-line with the Reuters Estimates consensus of $0.47; revenues rose 7.4% year/year to $183.1 mln vs the $184.1 mln consensus. Co issues in-line guidance for Q4, sees FFO of $0.50 vs. $0.50 consensus.
16:30 LOCM prelim ($0.71) vs ($0.67) Reuters consensus; revs $5.6 mln vs $5.65 mln Reuters consensus
16:29 CRK prelim $0.37 vs $0.27 Reuters consensus; revs $171.1 mln vs $158.42 mln Reuters consensus
16:28 F Ford Motor: UAW local leaders unanimously OK tentative Ford contract - WSJ (8.67 -0.2 -Update-
16:27 ASCA sees Q4 $0.22-0.26, excludes charges, vs $0.26 Reuters consensus
16:26 RWT Redwood Trust reports Q3 results; announces new buyback, regular and special dividends (25.47 -0.0
RWT reports Q3 GAAP EPS of ($2.1 vs $1.22 Reuters consensus. “To us, the best way to characterize Redwood’s economic progress in the third quarter is to call it mixed… On the one hand, our strategy of structuring our balance sheet in a way that minimizes liquidity risk paid off, and our prospects in the midst of the mortgage market turmoil are excellent and continue to improve. Net interest income is strong, operating expenses are down, and taxable income results are excellent. On the other hand, the amount of our assets for which we have heightened credit concerns has, while remaining relatively limited, grown during the quarter.” In the third quarter, mark-to-market adjustments for real estate securities, net of hedges, resulted in an accounting write-down of $757 mln for the quarter. Of this amount, $103 mln ($3.69 per share) reduced earnings and $654 mln ($24.46 per share) was recorded as a reduction of stockholders’ equity. Redwood believes that $28.01 represents a good overall per share estimate of the quarter-end fair market value of all its financial assets, less the fair market value of all its liabilities… In addition, RWT announced a new stock buyback program of up to 5 mln shares, and the declaration of a regular quarterly dividend and a special dividend. The co authorized the payment of a fourth quarter regular cash dividend of $0.75 per share, and a special cash dividend of $2.00 per share. The Board has indicated it intends to maintain Redwood’s regular dividend rate of $0.75 per share per quarter during 2008.
16:26 ASCA prelim $0.34, incl charge, may not be comparable to $0.34 Reuters consensus, $0.35 First Call; revs $265.4 mln vs $260.65 mln Reuters consensus
16:25 Wall St Inv Banks to offer $10 bln in Chrysler loans, according to sources - WSJ
WSJ reports in a sign of the gradual recovery of the corporate-loan mkt, Wall Street investment banks plan to launch on Wednesday an offering of up to $10 bln in loans for Chrysler’s automotive business, according to a person familiar with the matter. The offering amounts to a second try at a debt sale that was postponed in July amid gathering credit-market turmoil at the time. The loans are connected to the recent acquisition of Chrysler by private-equity co Cerberus Capital. The banks’ renewed efforts to find investors for the Chrysler loans this month come amid a recovery in the mkt for risky corporate debt in recent weeks.
16:25 SAFT Safety Insurance beats by $0.08 (34.89 -0.23)
Reports Q3 (Sep) earnings of $1.42 per share, $0.08 better than the Reuters Estimates consensus of $1.34 (2 ests); total revenue fell 1.7% year/year to $167.9 mln vs the single est of $166.5 mln.
16:24 IPHS Innophos Holdings beats by $0.04; misses on revs (6.35 +0.09)
Reports Q3 (Sep) earnings of $0.26 per share, $0.04 better than the Reuters Estimates consensus of $0.22; revenues rose 4.1% year/year to $146.40 mln vs the $148.60 mln consensus.
16:23 DNB Dun & Bradstreet misses by $0.01, reports revs in-line; reafirms FY07 guidance, issues FY08 guidance (94.13 -0.87)
Reports Q3 (Sep) earnings of $1.00 per share, $0.01 worse than the Reuters Estimates consensus of $1.01; revenues rose 8.5% year/year to $389.9 mln vs the $388 mln consensus. DNB reaffirms FY07 guidance for EPS growth of 13-16% on revenue growth of 6-8%. Sees FY08 EPS growth of 11-14% on revenue growth of 7-9%.
16:23 CECO Career Education misses by $0.02, misses on revs (34.87 +0.0
Reports Q3 (Sep) earnings of $0.21 per share, $0.02 worse than the Reuters Estimates consensus of $0.23; revenues fell 5.6% year/year to $404.4 mln vs the $409.6 mln consensus.
16:23 RWT Redwood Trust announces new stock buyback program of up to 5 mln shares (25.47 -0.0
16:22 DNB reaffirms FY07 guidance for EPS growth of 13-16% on revenue growth of 6-8%. Sees FY08 EPS growth of 11-14% on revenue growth of 7-9%.
16:22 HLS Healthsouth reports Q3 (Sep) results, revs in-line (20.16 -0.07)
Reports Q3 (Sep) loss of $0.40 per share, includes items, may not be comparable to the Reuters Estimates consensus of ($0.08); revenues rose 4.4% year/year to $431.6 mln vs the $433.6 mln consensus. Co says, “With the final SEC Settlement and Medicare Program Settlement payments being made in Q4 of 2007, we are well positioned to generate free cash flow in the future.”
16:22 CECO prelim $0.21 vs $0.23 Reuters consensus; revs $404.4 mln vs $409.59 mln Reuters consensus
16:22 CUZ Cousins Prop misses by $0.09 (25.74 -0.82)
Reports Q3 (Sep) funds from operations of $0.14 per share, $0.09 worse than the Reuters Estimates consensus of $0.23. Revs rose 40% YoY to $46.18 mln from $32.8 mln YoY.
16:21 DNB prelim $1.00, ex items vs $1.01 Reuters consensus, $1.00 First Call; revs $389.9 mln vs $388.04 mln Reuters consensus
16:21 CDR Cedar Shopping Centers misses by $0.01, reports revs in-line; guides FY07 EPS in-line (12.01 -0.10)
Reports Q3 (Sep) funds from operations of $0.31 per share, $0.01 worse than the Reuters Estimates consensus of $0.32; revenues rose 18.7% year/year to $37.5 mln vs the $37.7 mln consensus. Co issues in-line guidance for FY07, sees FFO of lower end of range of $1.25-1.30, excluding previously announced one-time charge of $0.03, vs. $1.23 consensus.
16:21 DIVX DivX beats by $0.05, beats on revs; guides Q4 EPS above consensus, revs in-line, names new CEO (11.98 -0.25)
Reports Q3 (Sep) earnings of $0.17 per share, excluding non-recurring items, $0.05 better than the Reuters Estimates consensus of $0.12; revenues rose 42.2% year/year to $21.9 mln vs the $20.5 mln consensus. Co issues mixed guidance for Q4, sees EPS of $0.16-0.18, excluding non-recurring items, vs. $0.14 consensus; sees Q4 revs of $22-23 mln vs. $23.14 mln consensus. Co also names Kevin Hell as CEO.
16:20 ODFL Old Dominion names David Congdon President and CEO effective January 1, 2008 (22.49 -0.21)
Co announces that the Board of Directors has appointed David Congdon, President and COO, to become President and CEO. In addition, Earl Congdon, Chairman and CEO, has been appointed Executive Chairman of the Board and John B. Yowell, Executive Vice President, will become Executive Vice President and COO. Each of these appointments will become effective on January 1, 2008. The Company also reported that the Board approved certain amendments to the Company’s Amended and Restated Bylaws, including amendments that eliminated the requirements that the Chairman of the Board of Directors also serve as CEO and that the President also serve as COO.
16:19 CCRT CompuCredit reports Q3 (Sep) results (16.36 -0.97)
Reports Q3 (Sep) earnings of $0.95 per share, includes charge, may not be comparable to the Reuters Estimates consensus of $1.30.
16:18 NVTL Novatel Wireless beats by $0.03, beats on revs; guides Q4 EPS above consensus, revs above consensus (26.42 +1.42)
Reports Q3 (Sep) earnings of $0.31 per share, excluding non-recurring items, $0.03 better than the Reuters Estimates consensus of $0.28; revenues rose 89.8% year/year to $104.6 mln vs the $101.5 mln consensus. Co issues upside guidance for Q4, sees EPS of $0.34, excluding non-recurring items, vs. $0.31 consensus; sees Q4 revs of $120.0 mln vs. $112.55 mln consensus.
16:18 MBLX Metabolix misses by $0.01, misses on revs (26.91 -0.92)
Reports Q3 (Sep) loss of $0.37 per share, $0.01 worse than the Reuters Estimates consensus of ($0.36); revenues fell 57.4% year/year to $0.2 mln vs the $0.4 mln consensus.
16:17 DAL Delta Air Lines achieves record October load factors (19.51 -0.42)
Co reported record load factors for consolidated system (79.6%), mainline system (79.9%) and total Latin system (73.6%) were all records for the month of October. System traffic increased 6.2% from October 2006 with a capacity increase of 2.9%. Domestic traffic in October 2007 increased 2.3% YoY on a 0.3% increase in capacity. International traffic in October 2007 increased 15.6% YoY on an 8.6% increase in capacity.
16:17 IPHS prelim $0.26 vs $0.22 Reuters consensus; revs $146.40 mln vs $148.60 mln Reuters consensus
16:17 ARE Alexandria RE beats by $0.01, beats on revs; guides FY07 EPS in-line (98.25 +0.35)
Reports Q3 (Sep) funds from operations of $1.45 per share, $0.01 better than the Reuters Estimates consensus of $1.44; revenues rose 22.8% year/year to $104.1 mln vs the $95.7 mln consensus. Co issues in-line guidance for FY07, sees FFO of $5.61 vs. $5.63 consensus.
16:16 ARE sees FY07 funds from operations of $5.61 vs $5.63 Reuters consensus
16:15 JADE LJ Intl announces new auditor (3.74 -0.2
The co announces announced that its Audit Committee has dismissed KPMG and has engaged Gruber as its independent registered accounting co. The completion of the co’s 2006 audit and the filing of the co’s 20-F Annual Report will meet the requirement imposed by the Nasdaq Listing Qualifications Panel when it granted LJI’s request for continued Nasdaq listing until the end of 2007.
16:15 EPIX EPIX Pharma achieves milestone for second discovery program in collaboration with GlaxoSmithKline (3.95 -0.11)
The co announces that it has achieved a key milestone related to the second of three discovery programs under its collaboration with GlaxoSmithKline (GSK). Using its proprietary, integrated computational-medicinal chemistry approach to drug discovery, EPIX has identified three lead candidates to move forward into lead optimization in this second G-protein coupled receptor discovery program. Under the collaboration, EPIX is entitled to receive a $3 mln milestone payment from GSK in the next 30 days. In August, EPIX announced that it had identified three lead candidates for the first discovery program, which entitled the company to a $3 mln milestone payment.
16:15 PKY Parkway Prop reports EPS in-line, revs in-line; guides FY07 EPS in-line (39.30 -0.20)
Reports Q3 (Sep) funds from operations of $0.96 per share, in-line with the Reuters Estimates consensus of $0.96; revenues rose 10.9% year/year to $61.2 mln vs the $60.9 mln consensus. Co issues in-line guidance for FY07, sees FFO of $3.80-4.00 vs. $3.89 consensus.
16:15 ARE prelim funds from operations of $1.45 vs $1.44 Reuters consensus; revs $104.1 mln vs $95.69 mln Reuters consensus
16:15 CCRT prelim $0.95 vs $1.30 Reuters consensus
16:15 QGEN Qiagen beats by $0.03, beats on revs; guides FY07 EPS above consensus, revs in-line (22.56 -0.21)
Reports Q3 (Sep) earnings of $0.17 per share, excluding non-recurring items, $0.03 better than the Reuters Estimates consensus of $0.14; revenues rose 49.8% year/year to $176.6 mln vs the $172.7 mln consensus. Co issues guidance for FY07, sees EPS of $0.61-0.62 vs. $0.59 consensus; sees FY07 revs of $614-635 mln vs. $634.15 mln consensus.
16:14 CUTR Cutera beats by $0.01, beats on revs; co discontinues giving guidance (20.51 -0.24)
Reports Q3 (Sep) earnings of $0.30 per share, excluding non-recurring items, $0.01 better than the Reuters Estimates consensus of $0.29; revenues rose 12.0% year/year to $28.1 mln vs the $27.7 mln consensus. CUTR- “recent signs of a slowing market growth rate, have made it more difficult to accurately predict our future financial performance” . CUTR- “we have elected to discontinue giving financial guidance”.
16:14 QMAR Quintana Maritime beats by $0.03, beats on revs (25.78 -1.42)
Reports Q3 (Sep) earnings of $0.39 per share, $0.03 better than the Reuters Estimates consensus of $0.36; revenues rose 156.0% year/year to $64 mln vs the $62.1 mln consensus. Co states, “We believe that the current size of the fleet together with our significant charter coverage will allow us to optimize our chartering practices in the future, including more aggressive trading of vessels in the spot market or under short term period charters if we determine that market conditions are appropriate. We believe this strategy would allow us to generate additional upside potential during a buoyant market without risking significant revenues in case of a market downturn.”
16:13 LLNW Limelight Networks beats by $0.04, beats on revs; issues Q4 guidance (12.35 +0.21)
Reports Q3 (Sep) earnings of $0.03 per share, excluding non-recurring items, $0.04 better than the First Call consensus of ($0.01); revenues rose 60.0% year/year to $28 mln vs the $26.29 mln consensus. Co sees Q4 revs of $28-30 mln vs $30.98 mln consensus.
16:13 RADN Radyne beats by $0.01, misses on revs (9.90 -0.03)
Reports Q3 (Sep) earnings of $0.20 per share, excluding stock options expense, $0.01 better than the Reuters Estimates consensus of $0.19; revenues rose 20.0% year/year to $38.4 mln vs the $38.8 mln consensus.
16:13 XCO Exco Resources beats by $0.14, beats on revs (16.52 -0.17)
Reports Q3 (Sep) earnings of $0.10 per share, $0.14 better than the Reuters Estimates consensus of ($0.04); total revenues rose 76.0% year/year to $326.2 mln vs the $278.2 mln two-analyst est. “We had a strong third quarter at EXCO, despite the decreases in natural gas prices, as we focused on an aggressive development program and integration of our recent acquisitions. Our ability to maintain our adjusted EBITDA during periods of declining prices emphasizes the importance of our hedging program to support our capital spending for development of our properties. Our development program will be at a very high level for the remainder of 2007 and we continue to actively review a number of acquisition opportunities.”
16:13 SIE Sierra Health Srvs beats by $0.04, reports revs in-line; guides FY07 EPS below consensus (42.00 -0.15)
Reports Q3 (Sep) earnings of $0.63 per share, excluding non-recurring items, $0.04 better than the Reuters Estimates consensus of $0.59; revenues rose 9.0% year/year to $468.9 mln vs the $471.5 mln consensus. Co issues downside guidance for FY07, sees EPS of $1.82-1.84 vs. $2.42 consensus.
16:12 WINS S M & A Corp beats by $0.02, beats on revs (6.75 -0.06)
Reports Q3 (Sep) earnings of $0.10 per share, $0.02 better than the Reuters Estimates consensus of $0.08; revenues rose 47.6% year/year to $25.1 mln vs the $22.3 mln consensus.
16:12 SWS prelim $0.28 vs single analyst est of $0.31; revs $112.5 mln, no ests
16:11 TMRK Terremark Worldwide misses by $0.20, beats on revs; guides Q3 revs below consensus; guides FY08 revs in-line (7.58 +0.0
Reports Q2 (Sep) loss of $0.27 per share, $0.20 worse than the Reuters Estimates consensus of ($0.07); revenues rose 29.0% year/year to $45.4 mln vs the $44.7 mln consensus. Co issues downside guidance for Q3, sees Q3 revs of $48-50 mln vs. $50.49 mln consensus. Co issues in-line guidance for FY08, sees FY08 revs of $185-190 mln vs. $186.70 mln consensus.
16:11 INVX Innovex misses by $0.13 (0.98 +0.0
Reports Q4 (Sep) loss of $0.32 per share, excluding non-recurring items, $0.13 worse than the single estimate of ($0.19); revenues fell 32.3% year/year to $21.8 mln vs the $21.3 mln estimate.
16:11 STAK Staktek Holdings beats by $0.01, beats on revs; guides Q4 revs above consensus (3.39 +0.02)
Reports Q3 (Sep) earnings of $0.02 per share, $0.01 better than the Reuters Estimates consensus of $0.01; revenues rose 32.9% year/year to $10.9 mln vs the $8.1 mln consensus. Co issues upside guidance for Q4, sees Q4 revs of $12.5-$14.5 vs. $9.20 mln consensus. “During the third quarter, we experienced strong demand for stacking services, which resulted in revenue that exceeded our previously stated guidance, excluding the revenue associated with Southland,” stated Wayne Lieberman, president and CEO.
16:11 BDE Bois D Arc Energy beats by $0.09, reports revs in-line (21.59 +0.54)
Reports Q3 (Sep) earnings of $0.32 per share, $0.09 better than the Reuters Estimates consensus of $0.23; revenues rose 31.3% year/year to $88 mln vs the $87.4 mln consensus.
16:11 VIRL Virage Logic beats by $0.02, beats on revs; guides Q1 EPS in-line, revs above consensus (8.18 +0.12)
Reports Q4 (Sep) earnings of $0.02 per share, $0.02 better than the Reuters Estimates consensus of ($0.00); revenues decreased 12.7% year/year to $13.1 mln vs the $12.4 mln consensus. Co issues mixed guidance for Q1, sees EPS of $0.02-0.04 vs. $0.03 consensus; sees Q1 revs of $13.5-14.5 mln vs. $13.13 mln consensus.
16:10 TXCO TXCO Resources reports Q3 EPS of $0.07 vs $0.05 two-analyst est; revs rose 31% YoY to $28.3 mln vs $26.50 mln single analyst estimate (12.47 +0.74)
16:10 BDE prelim $0.32 vs $0.23 Reuters consensus; revs $88.0 mln vs $87.40 mln Reuters consensus, $80.55 mln First Call
16:10 ATVI Activision beats by $0.03, beats on revs; guides Q3 EPS above consensus, revs above consensus; guides FY08 EPS above consensus, revs above consensus (22.90 )
Reports Q2 (Sep) earnings of $0.02 per share, $0.03 better than the Reuters Estimates consensus of ($0.01); revenues rose 68.9% year/year to $317.7 mln vs the $265.2 mln consensus. Co issues upside guidance for Q3, sees EPS of $0.55, excluding non-recurring items, vs. $0.50 consensus; sees Q3 revs of $1.05 bln vs. $891.73 mln consensus. Co issues upside guidance for FY08, sees EPS of $0.67-0.68, excluding $0.02-0.03 dilution from Bizarre acquisition and stock based compensation expense, vs. $0.65 consensus; sees FY08 revs of $2.07 vs. $1.92 bln consensus.
16:09 ASEI American Science & Engineering misses by $0.15, misses on revs (54.57 -4.40)
Reports Q2 (Sep) earnings of $0.48 per share, $0.15 worse than the Reuters Estimates consensus of $0.63; revenues rose 27.1% year/year to $37.6 mln vs the $43 mln consensus. Co states, “…Although product mix impacted gross margin for the quarter, it reflects a more diversified revenue stream and is in line with our fiscal year 2008 goal to drive revenue diversification through an expanded product portfolio…”
16:09 TNS TNS Inc beats by $0.05, beats on revs; guides Q4 (Dec) EPS in-line, revs in-line; guides FY07 (Dec) EPS in-line, revs in-line (15.80 -0.2
Reports Q3 (Sep) earnings of $0.29 per share, $0.05 better than the Reuters Estimates consensus of $0.24. Co issues in-line guidance for Q4 (Dec), sees EPS of 0.25-0.30 vs. $0.27 consensus; sees Q4 (Dec) revs of 82-85 vs. $82.85 mln consensus. Co issues in-line guidance for FY07 (Dec), sees EPS of 0.95-1.00 vs. $0.92 consensus; sees FY07 (Dec) revs of 319-322 vs. $316.56 mln consensus.
16:09 WMS WMS Industries misses by $0.01, beats on revs; guides Q2 revs below consensus; reaffirms FY08 revs guidance (34.59 +0.59)
Reports Q1 (Sep) earnings of $0.19 per share, $0.01 worse than the Reuters Estimates consensus of $0.20; revenues rose 19.8% year/year to $132.5 mln vs the $130.5 mln consensus. Co issues downside guidance for Q2, sees Q2 revs of $143-148 mln vs. $152.12 mln consensus. Co reaffirms guidance for FY08, sees FY08 revs of $595-615 mln vs. $610.98 mln consensus.
16:09 QGEN sees FY07 $0.61-0.62 vs $0.59 Reuters consensus; sees revs $614-635 mln vs $634.15 mln Reuters consensus
16:08 CUTR- “recent signs of a slowing market growth rate, have made it more difficult to accurately predict our future financial performance”
16:08 QGEN prelim $0.17 may not compare to $0.14 Reuters consensus; revs $176.6 mln vs $172.73 mln Reuters consensus
16:08 DIVX sees FY07 $0.57- $0.59 vs $0.49 Reuters consensus; sees revs $82.4 - $83.4 mln vs $82.27 mln Reuters consensus
16:08 CUTR- “we have elected to discontinue giving financial guidance”
16:07 TNS sees FY07 $0.95-1.00 vs $0.92 Reuters consensus; sees revs $319-322 mln vs $316.56 mln Reuters consensus
16:07 TMRK sees FY08 revs $185-190 mln vs $186.70 mln Reuters consensus
16:07 TMRK sees Q3 revs $48-50 mln vs $50.49 mln Reuters consensus
16:07 NVTL sees Q4 $0.34 vs $0.31 Reuters consensus; sees revs $120.00 mln vs $112.55 mln Reuters consensus
16:07 CUTR prelim $0.30 vs $0.29 Reuters consensus; revs $28.1 mln vs $27.71 mln Reuters consensus
16:07 TNS sees Q4 $0.25-0.30 vs $0.27 Reuters consensus; sees revs $82-85 mln vs $82.85 mln Reuters consensus
16:07 MBLX prelim ($0.37) vs ($0.36) Reuters consensus; revs $0.18 mln vs $0.44 mln Reuters consensus
16:07 TMRK prelim ($0.27) may not compare to ($0.07) Reuters consensus; revs $45.4 mln vs $44.74 mln Reuters consensus
16:07 DIVX DivX names Kevin Hell as CEO (11.98 -0.25)
16:07 SIE sees FY07 $1.82-1.84 vs $2.42 Reuters consensus
16:07 NVTL prelim $0.31 vs $0.28 Reuters consensus; revs $104.6 mln vs $101.53 mln Reuters consensus
16:06 TNS prelim $0.29 vs $0.24 Reuters consensus; revs $84.5 mln vs $81.65 mln Reuters consensus
16:06 SOLD Housevalues misses by $0.01, misses on revs (3.90 +0.05)
Reports Q3 (Sep) loss of $0.04 per share, $0.01 worse than the Reuters Estimates consensus of ($0.03); revenues fell 34.6% year/year to $13.8 mln vs the $14.8 mln consensus.
16:06 DIVX prelim $0.14 vs $0.12 Reuters consensus; revs $21.90 mln vs $20.54 mln Reuters consensus
16:06 LLNW sees Q4 revs $28-30 mln vs $30.98 mln First Call consensus
16:06 VIRL sees Q1 $0.02-0.04 vs $0.03 Reuters consensus; sees revs $13.5-14.5 mln vs $13.13 mln Reuters consensus
16:06 VARI Varian acquires Analogix business (69.97 -0.23)
The co announces it has acquired the assets of Analogix for approximately $11 mln in cash plus assumed net debt, subject to certain net asset adjustments. The transaction also includes the opportunity for additional purchase price payments over three years, depending on future milestones and financial performance. Those future payments could total up to $4 mln if performance targets are achieved.
16:06 SYMC Symantec to Acquire Vontu for $350 mln; expects it to be $0.02 dilutive to FY08 (18.36 -0.15)
Co announces it has signed a definitive agreement to acquire Vontu for $350 mln, which will be paid in cash and assumed options. The acquisition is expected to close in the fourth calendar quarter of 2007, subject to receiving regulatory approvals and satisfaction of other customary closing conditions. Symantec expects this transaction to be $0.02 dilutive to FY08 non-GAAP earnings per share and expects FY08 GAAP earnings per share to be more diluted due to purchase accounting, stock based compensation and acquisition related charges associated with the transaction.
16:06 NTY NBTY Inc reports EPS in-line, revs in-line
Reports Q4 (Sep) earnings of $0.73 per share, in-line with the Reuters Estimates consensus of $0.73; revenues rose 6.1% year/year to $496.4 mln vs the $499.3 mln consensus. CEO comments, “Our significant increases in revenue and profitability are reflected in NBTY’s ongoing initiatives to drive sales and expand our premiere position as the leading nutritional supplement company in the world. Our growing financial strength and expanding market position continue to play a vital role in our ability to generate future growth and shareholder value.”
16:06 SIE prelim $0.63 excluding charge vs $0.59 Reuters consensus, $0.61 First Call; revs $468.9 mln vs $471.53 mln Reuters consensus
16:05 QMAR prelim $0.39 vs $0.36 Reuters consensus; revs $64.0 mln vs $62.05 mln Reuters consensus
16:05 LLNW prelim non-GAAP $0.03 vs ($0.01) First Call consensus; revs $28.0 vs $26.29 mln First Call consensus
16:05 VIRL prelim $0.02 vs $0.00 Reuters consensus; revs $13.1 mln vs $12.36 mln Reuters consensus
16:05 ATVI prelim $0.02, ex items vs ($0.01) Reuters consensus; revs $317.74 mln vs $265.20 mln Reuters consensus
16:05 WPTE WPT Enterprises beats by $0.10, beats on revs; guides Q4 revs below consensus (2.31 -0.02)
Reports Q3 (Sep) loss of $0.11 per share, $0.10 better than the Reuters Estimates consensus of ($0.21); revenues fell 25.0% year/year to $4.4 mln vs the $4.4 mln consensus. Co issues downside guidance for Q4, sees Q4 revs of $4.0-4.5 mln vs. $4.86 mln consensus.
16:05 LCC US Airways Group reports Oct. traffic (25.15 -0.73)
The co announces it reported October and year-to-date traffic results for 2007. Revenue passenger miles for the month were 4.9 bln, down 1.5% from October 2006. Capacity was 6.1 bln available seat miles, down 5.5% from October 2006. Passenger load factor set a record for the month of October at 80.5%, up 3.3 points versus October 2006.
16:04 ATVI sees Q3 $0.55 vs $0.50 Reuters consensus; sees revs $1.05 bln vs $891.73 mln Reuters consensus
16:04 ATVI raises FY08 guidance to $0.65, ex items vs $0.65 Reuters consensus; sees revs $2.07 bln vs $1.92 bln Reuters consensus
16:04 ATSI ATS Medical reports Q3 results; guides in line (1.63 -0.10)
Co reports Q3 EPS of ($0.06) vs ($0.0 Reuters consensus; revs rose 33% YoY to $12.2 mln vs $11.65 mln Reuters consensus. Sees FY07 revs $49-50 mln vs $49.12 mln Reuters consensus. “As we look ahead to 2008 we expect to harvest the fruits of our significant investments in atrial fibrillation and heart valve therapy in the form of multiple new product introductions. In each instance, these new products will provide additional leverage of our sales and distribution organization and contribute materially to our profitability objective for 2008.”
16:04 RGN Regenerex Biopharam: Researchers show TB4’s cardioprotective effects in ischemia-reperfusion injury (1.25 -0.04)
Co announces that at an American Heart Association meeting in Orlando, Florida, an independent international team of medical researchers presented new data showing that administration of thymosin beta 4 significantly decreased heart damage after cardiac ischemia and reperfusion in pigs. In this study, the animals underwent LAD occlusion for 60 minutes to simulate a heart attack and were then reperfused to simulate the standard of care for heart attack patients. TB4 or placebo was then infused directly into the damaged area. TB4 significantly decreased cardiac tissue damage, enhanced function of the damaged heart tissue, and reduced MPO levels when compared to placebo. According to the researchers, “Consistently, TB4 protein suffices to provide significant cardioprotection after ischemia and reperfusion.”
16:03 AOB sees Y08 organic rev growth of at least 30%
16:03 CDR reaffirms FY07 funds from operations to be on the lower end of the range of $1.25-1.30, excl $0.03 charge, vs $1.23 Reuters consensus
16:03 HLS prelim ($0.40) include items not comparable to vs ($0.0 Reuters consensus, ($0.10) First Call; revs $431.6 mln vs $433.58 mln Reuters consensus
16:03 JAVA Sun Microsystems beats by $0.03, misses on revs (5.71 +0.11)
Reports Q1 (Sep) earnings of $0.06 per share, excluding non-recurring items, $0.03 better than the Reuters Estimates consensus of $0.03; revenues rose 0.9% year/year to $3.22 bln vs the $3.26 bln consensus.
16:03 SOLD prelim ($0.04) vs ($0.03) Reuters consensus; revs $13.8 mln vs $14.75 mln Reuters consensus
16:03 AOB sees FY07 $0.60 vs $0.60 Reuters consensus; sees revs $160 mln vs $158.09 mln Reuters consensus
16:02 AOB prelim $0.16 vs $0.15 Reuters consensus; revs $43.5 mln vs $41.75 mln Reuters consensus
16:02 STAK sees Q4 revs $12.5 - $14.5 mln vs $9.20 mln Reuters consensus
16:02 PKY sees FY07 funds from operations of $3.80-4.00 vs $3.89 Reuters consensus
16:02 CDR prelim funds from operations of $0.31 vs $0.32 Reuters consensus; revs $37.5 mln vs $37.73 mln Reuters consensus
16:01 STAK prelim $0.02 vs $0.01 Reuters consensus; revs $10.9 mln vs $8.10 mln Reuters consensus
16:01 PKY prelim funds from operations of $0.96 vs $0.96 Reuters consensus; revs $61.22 mln vs $60.89 mln Reuters consensus
16:01 RADN prelim $0.20 vs $0.19 Reuters consensus; revs $38.40 mln vs $38.83 mln Reuters consensus
16:01 JAVA prelim $0.06, ex charge vs $0.03 Reuters consensus; revs $3.22 bln vs $3.26 bln Reuters consensus
16:01 SOLD HouseValues acquires realty generator (3.90 +0.05)
The co announces acquired it has acquired Realty Generator, a leading provider of marketing and technology solutions to real estate brokerage companies. Realty Generator enables brokerage cos to dramatically increase both their revenue and their bottom line while providing them with a comprehensive internet marketing system for cultivating their leads and managing their real estate business. HouseValues expects the Realty Generator acquisition to be accretive to Adjusted EBITDA in 2008.
16:01 RADN prelim $0.19 vs $0.19 Reuters consensus; revs $38.4 mln vs $38.83 mln Reuters consensus
16:01 XCO prelim $0.10 vs ($0.04) Reuters consensus; revs $326.2 mln, may not be comparable to $278.22 mln Reuters consensus
16:01 ASEI prelim $0.48 vs $0.63 Reuters consensus; revs $37.6 mln vs $42.97 mln Reuters consensus
16:01 WMS prelim $0.19 vs $0.20 Reuters consensus; revs $132.5 mln vs $130.49 mln Reuters consensus
16:01 PCLN Priceline.com eliminates airline ticket booking fees (89.05 -1.76) -Update-
16:00 PDCO Patterson Companies acquires developer and marketer of industry-leading practice management software for physical therapists (39.00 -0.46)
Co announces the acquisition of Advanced Practice Systems (known in the marketplace as PTOS Software), the developer and marketer of the industry-leading practice management software for physical therapists. PTOS will become part of Patterson Medical, Patterson’s rehabilitation supply and equipment unit. Terms of the transaction were not disclosed.
16:00 NTY prelim $0.73 vs $0.73 Reuters consensus; revs $496 mln vs $499.33 mln Reuters consensus
16:00 INVX prelim ($0.32) vs ($0.19) single estimate; revs $21.8 mln vs $21.31 mln single estimate
16:00 CUZ prelim funds from operations of $0.14 vs $0.23 Reuters consensus
16:00 WPTE sees Q4 revs $4.0-4.5 mln vs $4.86 mln Reuters consensus
16:00 WPTE prelim ($0.11) vs ($0.21) Reuters consensus; revs $4.4 mln vs $4.35 mln Reuters consensus
16:00 AHT Ashford Hospitality completes $62 mln of asset sales (8.71 -0.07)
